You are here

Article Text

Article menu
Download PDFPDF
Perspective
Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research
  1. R Donnelly1,
  2. I Idris1,
  3. J V Forrester2
  1. 1School of Medical and Surgical Sciences, University of Nottingham, UK
  2. 2Department of Ophthalmology, University of Aberdeen, UK
  1. Correspondence to: Professor Richard Donnelly Division of Vascular Medicine, University of Nottingham, Derbyshire Royal Infirmary, Derby DE1 2QY, UK; Richard.donnellynottingham.ac.uk

Abstract

Translational research in practice: a PKC­β inhibitor for diabetic retinopathy

  • diabetic retinopathy
  • maculopathy
  • protein kinase C
  • ruboxistaurin

https://doi.org/10.1136/bjo.88.1.145

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Conflict of interest: RD and JF have received consultancy fees from Eli Lilly & Co for attending meetings of a UK scientific advisory board for ruboxistaurin. II was supported in part through an unrestricted educational grant from Eli Lilly & Co to the University of Nottingham.